1. Home
  2. DNUT vs ZVRA Comparison

DNUT vs ZVRA Comparison

Compare DNUT & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

HOLD

Current Price

$3.13

Market Cap

541.3M

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$8.37

Market Cap

502.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNUT
ZVRA
Founded
1937
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
541.3M
502.7M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
DNUT
ZVRA
Price
$3.13
$8.37
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$6.22
$21.71
AVG Volume (30 Days)
2.3M
982.1K
Earning Date
02-24-2026
03-10-2026
Dividend Yield
1.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.54
Revenue
$1,534,272,000.00
$84,388,000.00
Revenue This Year
N/A
$333.64
Revenue Next Year
$0.19
$44.19
P/E Ratio
N/A
$16.64
Revenue Growth
N/A
244.60
52 Week Low
$2.50
$6.19
52 Week High
$9.43
$13.16

Technical Indicators

Market Signals
Indicator
DNUT
ZVRA
Relative Strength Index (RSI) 30.33 41.76
Support Level $3.03 $8.51
Resistance Level $3.31 $9.62
Average True Range (ATR) 0.15 0.51
MACD -0.02 -0.03
Stochastic Oscillator 13.61 2.02

Price Performance

Historical Comparison
DNUT
ZVRA

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Share on Social Networks: